SCHEMBL7119116

SCHEMBL7119116

Oc1cccc(O)c1C(O)C(Cl)(Cl)Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TDP1 Q9NUW8 4/20 0.38
CA2 P00918 3/20 0.38
HPGD P15428 3/20 0.38
ALOX15 P16050 3/20 0.38
RECQL P46063 3/20 0.38
HSD17B10 Q99714 3/20 0.38
LMNA P02545 3/20 0.38
EGFR P00533 2/20 0.38
FYN P06241 2/20 0.38
MMP9 P14780 2/20 0.38
CA1 P00915 2/20 0.38
ADAMTS4 O75173 1/20 0.38
MMP2 P08253 1/20 0.38
MMP8 P22894 1/20 0.38
CA6 P23280 1/20 0.38
CDK2 P24941 1/20 0.38
MMP12 P39900 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
TSHR P16473 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122682 0.76 ESR1 (0.33) TDP1HPGDLMNAEGFRCYP3A4
SCHEMBL7116572 0.76 CA2 (0.38) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL24824296 0.76 TRPA1 (0.41) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL7126782 0.76 LMNA (0.44) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL7131111 0.74 GABRA1 (0.48) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL23149871 0.74 CES2 (0.44) ALDH1A1ALOX15CYP3A4CYP1A2
SCHEMBL7118915 0.73 G6PD (0.37) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL10979315 0.71 ALOX15 (0.47) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL789377 0.67 GABRA1 (0.44) ALDH1A1TDP1CA2HPGDALOX15
SCHEMBL3697805 0.67 ADRB1 (0.48) ALDH1A1CA2HSD17B10LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030144541-A1 Process for preparing alpha-halogenated retones RHODIA CHIMIE (FR) 2003-07-31 US disclosed
EP-1250303-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2002-10-23 EP disclosed
WO-2001055067-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144541-A1 Process for preparing alpha-halogenated retones ADH1A, ADH1C, RER1 ALDH1A1 15/4885TDP1 2515/4885CA2 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.